Grundinformationen
- Standard-SMILES
CN(C)CC(=O)O- InChIKey
FFDGPVCHZBVARC-UHFFFAOYSA-N- Summenformel
- C4H9NO2
- Durchschnittliche Molmasse
- 103,12 g/mol
- Monoisotopische Masse
- 103,06332853
Namen und Bezeichner
- Bevorzugter Name
- N,N-Dimethylglycine
- IUPAC
- 2-(dimethylamino)acetic acid
- Lokaler Name
- N,N-Dimethylglycin
- Englischer Name
- N,N-Dimethylglycine
- Summenformel
- C4H9NO2
- Molmasse
- 103.12
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
1118-68-9- PubChem CID
- 673
- DTXSID
DTXSID6074336- ChEMBL
CHEMBL1232274- ChEBI
CHEBI:17724- UNII
- 7797M4CPPA
- EC Number
- 214-267-8
- Nikkaji
- J135.420E
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -2,9
- Polarare Oberfläche (TPSA)
- 40,5 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 2
- Schwere Atome
- 7
- Formalladung
- 0
- Komplexität
- 70
Experimentelle und physikochemische Eigenschaften
LogP
-2.91
-2.91
Melting Point
185.5
185.5 °C
Collision Cross Section
119.7 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
116 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]
123.1 Ų [M+H]+
Physikochemische Eigenschaften
- Schmelzpunkt
- 178 · 178-182 °C(lit.)
- Siedepunkt
- 193.35 °C · 193.35°C (rough estimate)
- Dichte
- 1 g/cm3 · 1 g/cm3
- Brechungsindex
- 1.4674 · 1.4674 (estimate)
- storage temp.
- Keep in dark place,Sealed in dry,Room Temperature
- Löslichkeit
- Methanol (Slightly), Water (Slightly)
- pka
- 9.89 · 9.89(at 25℃)
- Aggregatzustand
- Crystalline Powder
- Farbe
- White to slightly yellow
- Wasserlöslichkeit
- soluble
- Merck
- 14 · 14,3244
- BRN
- 1700261 · 1700261
- InChI
- 1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)
- InChIKey
- FFDGPVCHZBVARC-UHFFFAOYSA-N
- SMILES
- CN(C)CC(O)=O
- CAS Datenbank
- 1118 · 1118-68-9(CAS DataBase Reference)
- EPA chemische Informationen
- Glycine, N,N-dimethyl- (1118-68-9)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 53.2% (58 of 109) of all reports.
Warning
H302 (46.8%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 109 reports by companies from 4 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 58 of 109 reports by companies.;There are 3 notifications provided by 51 of 109 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Regulatory Information
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/19838
Dimethylglycine: Non hazardous
Regulatorische Informationen
Regulatory Information
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/19838
Dimethylglycine: Non hazardous
Sicherheitsdaten
- F
- 3
- wgk
- 3
- tsca
- TSCA listed
- hs_code
- 29224999
- RTECS-Nr.
- MB9865000
- risk_code
- 22-36/37/38
- Toxizität
- rat,LD50,oral,> 650mg/kg (650mg/kg),BEHAVIORAL: ATAXIABLOOD: CHANGES IN SPLEENGASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA",Acute Toxicity Data. Journal of the American College of Toxicology, Part B. Vol. 1, Pg. 199, 1992.
- hazard_code
- Xn,Xi
- safety_code
- 24/25-36/37-26
- hazard_class
- IRRITANT
- Speicherklasse
- 11 - Combustible Solids
Chemie und Industrie
Pharmakologische Informationen
Metabolite Pathways
3-Phosphoglycerate dehydrogenase deficiency;Cystathionine Beta-Synthase Deficiency;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);Dimethylglycine Dehydrogenase Deficiency;Dimethylglycine Dehydrogenase Deficiency;Glycine N-methyltransferase Deficiency;Glycine, serine and threonine metabolism;Glycine, serine and threonine metabolism;Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type;Hyperglycinemia, non-ketotic;Total 18 pathways, visit the HMDB page for details
Verwendung und Herstellung
Anwendungen
BeschreibungN,N-Dimethylglycine (DMG) is a N-methylated product of the amino acid glycine. It is found in beans and liver. It can be formed from trimethylglycine upon the loss of one of its methyl groups. It is also a byproduct of the metabolism of choline. When DMG was first discovered, it was referred to as vitamin B16, but, unlike true B vitamins, deficiency of DMG in the diet does not lead to any ill-effects meaning it does not meet the definition of a vitamin. It is used in comparative analysis with other N-methylated glycines. N,N-Dimethylglycine is used in the development of glycine-based ionic liquids and emulsifiers, and as a substrate to identify, differentiate and characterize amino acid methyltransferase(s). It is potentially useful as a biomarker of protein degradation in COPD patients.
HistoryN,N-Dimethylglycine was discovered in 1943. It is found in some but not all formulations of pangamic acid (vitamin B15). Pangamic acid has been sold as a dietary supplement in the United States at least since the late 1970s, when the lay press celebrated its benefits. Although pangamic acid is also known as vitamin B16, it is not actually a vitamin because no deficiency state has been identified, and it has no known nutritional value.
VerwendenN,N-Dimethylglycine is used as an athletic performance enhancer and immunostimulant. It is also used in the treatment of autism, epilepsy and mitochondrial disease. It is also employed as a biomarker of protein degradation in chronic obstructive lung disease (COPD) patients. Further, it is used as a substrate to identify, differentiate and characterize amino acid methyltransferase. It plays an important role for the development of glycine-based ionic liquids and emulsifiers.
Darstellung
synthetischeN,N-Dimethylglycine is commercially available as the free form amino acid, and as the hydrochloride salt [2491-06-7 ]. DMG may be prepared by the alkylation of glycine via the Eschweiler–Clarke reaction. In this reaction, glycine is treated with aqueous formaldehyde in formic acid that serves as both solvent and reductant. Hydrochloric acid is added thereafter to give the hydrochloride salt. The free amino acid may been obtained by neutralization of the acid salt, which has been performed with silver oxide. H2NCH2COOH + 2 CH2O + 2 HCOOH →(CH3)2NCH2COOH + 2 CO2 + 2 H2O.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: N,N-dimethylglycine is an N-methylglycine that is glycine carrying two N-methyl substituents. It has a role as a human metabolite, a Daphnia magna metabolite and a mouse metabolite. It is a N-methyl-amino acid and a member of N-methylglycines. It is a tautomer of a N,N-dimethylglycine zwitterion.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…